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PHA406 – Therapeutics B 
DURATION 
 
Reading Time: 10 minutes 
Writing Time: 180 minutes 
 
INSTRUCTIONS TO CANDIDATES 
This examination has 3 (A, B and C) Sections: 
Section A contains Forty (40) Multiple Choice Questions.  Answer ALL questions on the Faculty/School 
supplied Multiple Choice Answer Sheet.  Total marks allocated: Twenty (20). 
Suggested time allocation: Sixty (60) minutes. 
Section B contains Four (4) Extended-Answer Questions.  Answer ALL questions in one of the 16-page 
Booklets provided.  Total marks allocated: Forty (40). 
Suggested time allocation: Sixty (60) minutes. 
Section C contains Two (2) Case Studies.  Answer ALL questions in one of the 16-page Booklet provided.  
Use a new booklet.  Total marks allocated: Forty (40). 
Suggested time allocation: Sixty (60) minutes. 
 
EXAM CONDITIONS 
You may begin writing from the commencement of the examination session.  The reading time indicated above is 
provided as a guide only. 
This is a CLOSED BOOK examination 
No calculators are permitted 
No handwritten notes are permitted 
No dictionaries are permitted 
ADDITIONAL AUTHORISED MATERIALS EXAMINATION MATERIALS TO BE SUPPLIED 
 




2 x 16 Page Book 
1 x Scrap Paper 
Faculty/School Multiple Choice Answer Sheet 
 
Family Name  
Given Name/s  
Student Number       
Teaching Period Semester 2, 2017 
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Section A 
Multiple Choice Questions 
Total No of Marks for this section: 20 
Answer ALL Questions 
 
Mark the answers for this section on the 100-MCQ Answer Sheet provided.  Please ensure that your name and 
student number have been written on the Answer Sheet. 
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Total No of Marks for this section: 40 
Answer ALL Questions 
 
Answer this section in one of the 16-page Answer Booklets provided. 
Marks for each section are indicated.  Suggested time allocation for Section B: 60 mins 
 
 
Question 1 (multiple topics) 
a. Briefly describe the pathophysiology of Central Diabetes Insipidus and discuss the 
therapeutic agents available for the treatment of this condition.  Include in your answer the 
mechanism(s) of action of these agents and any adverse effects, contraindications and 
precautions when using these agents. 
 (5 marks) 
b. Describe THREE (3) different classes of commonly used pharmacological agents for the 
treatment of primary open angle glaucoma (POAG).  Include in your answer the mechanisms 
of action of these agents in reducing intraocular pressure, and any adverse effects. 
 (5 marks) 
 
 
Question 2 (multiple topics) 
Discuss and compare the following aspects of schizophrenia and anxiety disorders. 
 Aetiology 
 Clinical presentation 
 Prognosis and aim of therapy 
 (10 marks) 
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Question 3 (multiple topics) 
Describe the aetiology, pathophysiology, clinical presentations and management/treatment 
plan(s) for the following disorders. 
i. Hyperthyroidism 
ii. Hyperparathyroidism 







Question 4  
Describe FIVE (5) common causes of insomnia and recommend appropriate pharmacological 
(include mechanisms of action) and non-pharmacological therapies for the management and 
prevention of insomnia. 








E n d  o f  S e c t i o n  B  
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Total No of Marks for this section: 40 
Answer ALL Questions 
 
Answer this section in one of the 16-page Answer Booklets provided.  Use a new booklet. 
Marks for each section are indicated.  Suggested time allocation for Section C: 60 mins 
 
Question 1 (20 marks) 
BA, a 60-year-old man (65kg) is hospitalised because of severe nausea, vomiting and diarrhoea.  
He admits to having experienced increasing fatigue and malaise, poor appetite and a 9-kg weight 
loss over the last 4 months.  He feels dizzy in the morning and lightheaded after standing for more 
than an hour.  He denies any skin changes or prolonged sun exposure but you notice that his face, 
hands, chest and back are conspicuously tanned.  His skin also shows decreased elasticity – an 
indication of dehydration.  He has no history of hypertension, diabetes, asthma or tuberculosis 
and takes no medication. 
Physical examination reveals that his supine blood pressure (BP) is 106/68 mmHg with a pulse rate 
of 90bpm.  His standing BP is 80/50 mmHg and his standing pulse is 104 bpm.  No heart 
abnormalities are noted in his ECG and his lungs are clear.  Results from other examinations (head, 
eyes, ear, nose, throat, testes and CNS) are unremarkable, except for increased bowel sounds and 
bilateral adrenal calcification from his abdominal radiographical study. 
The following laboratory data are obtained: 
Na+ 128 135-145 mmol/L 
Cl- 96 95-110 mmol/L 
K+ 5.9 3.4-4.5 mmol/L 
Ca2+ 2.78 2.1-2.6 mmol/L 
Bicarbonate 20 22-32 mmol/L 
Creatinine 177 60-120 μmol/L 
Urea 14 3-8 mmol/L 
Haemoglobin 106 
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BA receives appropriate treatment for his initial condition but seven months later, he becomes 
severely fatigued and weak, and complains of cold intolerance, dry and cold skin, somnolence 
and constipation.  Physical examination at that time reveals a pale patient with a supine BP of 
110/60mmHg and pulse of 64 bpm.  He weighs 72kg.  Mild and diffuse thyromegaly is present. 
Laboratory data are as follows: 
Na+ 135 135-145 mmol/L 
Cl- 99 95-110 mmol/L 
K+ 4.5 3.4-4.5 mmol/L 
Bicarbonate 25 22-32 mmol/L 
Creatinine 88 60-120 μmol/L 
Urea 6.5 3-8 mmol/L 






Fasting glucose 4.3 3-5.4 mmol/L 
Free T4 3.0 10-25 picomol/L 
TSH 16 0.4-5 mIU/L 
 





Please see next page for questions 
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a. What is the most likely condition BA has when he is hospitalised initially? 
 (1 mark) 
b. Discuss the signs and symptoms exhibited by BA and his laboratory results that are 
consistent with your initial impression (in part a). 
You need to discuss the reasons for his signs and symptoms, and abnormal 
laboratory results e.g. hyponatraemia...why and how, plus others. 
 (5 marks) 
c. Which laboratory test can be used to confirm your initial impression?  In your 
answer, describe briefly how this test works. 
 (3 marks) 
d. What would you recommend as initial therapies for BA? 
 (2 marks) 
e. What is the most important advice (key aspects of self-care) to give BA? 
 (4 marks) 
f. Based on the findings in BA 7 months later, what kind of additional disease does he 
develop?  Discuss how he should be treated (include the agent, steps in initiating 
the treatment and any monitoring required). 




Please see next page for Case Study 2 
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Question 2 (20 marks) 
MN is a 73-year-old woman presented to the emergency department by her family after she 
develops some strange and challenging behaviours.  During the examination, you notice she is 
confused, agitated, drowsy and names the incorrect month and season.  She scores a 12/30 on 
the MMSE (Mini-Mental State Examination), missing several answers because she had significant 
difficulty focusing on the questions.  Her blood pressure and heart rate are elevated. 
MN’s daughter is present at her bedside and has concerns about her mother, saying that on 
several occasions in the last few days, she had not been herself and had rambling speech, 
appeared to be confused and was asking the same question repeatedly.  At other times, however, 
she was back to normal.  The daughter also notes that since last year, her mother has had several 
episodes of confusion involving word-finding difficulties and slurred speech.  Although MN had 
been driving and completing basic errands prior to her admission, her daughter had to start 
managing her finances several months ago. 
In her hospital admission record, you notice that MN was admitted last year with a Transient 
Ischaemic Attack (TIA).  She suffered weakness to her left face, arm and leg, and had slurred 
speech.  An MRI of the head and neck showed a subacute right middle cerebral artery infarct and 
patent intracranial vessels.  MN’s TIA was resolved by the administration of a thrombolytic 
alteplase.  She suffered a fall 2 days prior to her last discharge but sustained no visible injuries. 
MN is 160cm in height and weighs 98kg.  She has no known drug allergies.  She is also recovering 
from a recent episode of urinary tract infection. 
 
MN’s medical history includes: 
Hypertension Chronic lower back pain 
Type II diabetes mellitus Hearing loss 
Hyperlipidaemia Alcoholism (but claims she has 
reduced her alcohol intake) 
Osteoarthritis Chronic liver disease (Child-Pugh 
class A) 
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Her regular medications (in a webster pack) include: 
Aspirin  100mg daily Glipizide 5mg twice daily 
Simvastatin 40mg daily hs Multivitamin 1 tablet daily 
Omeprazole  20mg daily Ducosate 100mg twice daily 
Propranolol 40mg twice daily Paracetamol/codeine 500/30mg q4-6h PRN 
Hydrochlorothiazide  12.5mg daily Zolpidem (Stildem®) 5mg hs PRN 
Oxycodone extended 
release 
10mg twice daily Hiprex (lowers urine 
pH to prevent urinary 
tract infection) 
1g twice daily 
 
a. Suggest FOUR (4) most likely causes of MN’s current complaints.  Explain your answer 
with reference to her risk factors and clinical presentations. 
 (8 marks) 
b. Identify and discuss the diagnostic tests or examination tools which can be used to 
confirm or exclude the causes you have suggested in part a. 
  (4 marks) 
c. Outline the immediate and long-term management plans you would recommend for 
treating MN’s conditions.  Justify your recommendations. 
 (8 marks) 
 
 
E nd  o f  S e ct i on  C  
End of  Exam Paper  
 
 
